Related News

Longer Course of Imatinib Better in Trial for GI Stromal Tumor

Mar 28, 2012

Improves survival in post-op patients at high risk for recurrence of gastrointestinal stromal tumor


Lexatumumab Tolerated for Pediatric Solid Tumors

Oct 17, 2012

Drug may mediate some clinical activity; tolerated at 10 mg, maximum dose identified in adults


Imaging Method Can Assess Solid Tumor Aggressiveness

Oct 2, 2012

Contrast-enhanced MRI can measure interstitial fluid pressure; may be biomarker of metastasis